ERO1LB anticorps (C-Term)
Aperçu rapide pour ERO1LB anticorps (C-Term) (ABIN2262076)
Antigène
Voir toutes ERO1LB AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 274-304, C-Term
-
Réactivité croisée
- Humain, Souris
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu Mo
-
Attributs du produit
- ERO1LB, CT (ERO1LB, ERO1-like protein beta, Endoplasmic oxidoreductin-1-like protein B, Oxidoreductin-1-L-beta)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogène
- ERO1LB antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 274-304 amino acids from the C-terminal region of human ERO1LB.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- ERO1LB (ERO1-Like beta (ERO1LB))
-
Autre désignation
- ERO1LB
-
UniProt
- Q86YB8
-
Pathways
- SARS-CoV-2 Protein Interactome
Antigène
-